Synthecon: 3D Culture Systems for 3D World!
HOMEGALLERYTECHNICAL RESOURCESPRODUCTSRESEARCH PUBLICATIONSNEWS COMPANYBLOG

Research Spotlight

Rungarunlert S, Ferreira JN, Dinnyes A- April 2016

Pluripotent stem cells are an exciting tool to generate a variety of cell types for therapuetic applications. There is an immenent and widespread need for cell therapies which target heart failure, specifically those producing cardiomyocytes from stem cell populations. A bioreactor based technology, which can produce PSC-derived embyroid bodies, that can later differentiate into cardiomyocytes at a large scale is needed, since cardiomyocytes in vivo have limited proliferative and self-healing capacity. In this recent study, Synthecon's RCCS showed a scalable and consistent method of producing embryoid bodies from pluripotent stem cells, and further cardiomyogenic differentiation.

Read the abstract here
 
Single Use 3D BioreactorsAutoclavable 3D BioreactorsStem Cell Culture SystemsPerfusion Bioreactors Nanobiomatrix ScaffoldsBiostructure Matrix Scaffolds
Synthecon, Incorporated | 8977 Interchange Dr. | Houston, Texas 77054 | (713) 741-2582 | Toll Free (800) 853-0740
Website by SinyakCreative
© 2022 Synthecon, Incorporated, All Rights Reserved